Medicus Pharma earnings were -$16.5M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MDCX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$6.2M, up 21% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MDCX reported annual earnings of -$11.2M, with 109.9% growth. The next MDCX earnings date is Aug 21, 2025.
On MDCX's earnings call on Invalid Date, Medicus Pharma (NASDAQ: MDCX) reported Q2 2025 earnings per share (EPS) of -$0.43, up 2.27% year over year. Total MDCX earnings for the quarter were -$6.18 million. In the same quarter last year, Medicus Pharma's earnings per share (EPS) was -$0.44.
The next MDCX earnings date is Invalid Date. Add MDCX to your watchlist to be reminded of Medicus Pharma's next earnings date.
Is Medicus Pharma profitable or losing money?
As of the last Medicus Pharma earnings report, Medicus Pharma is currently losing money. Medicus Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$16.51 million, a 70.54% increase year over year.
What was MDCX's earnings growth in the past year?
As of Medicus Pharma's earnings date in Invalid Date, Medicus Pharma's earnings has grown year over year. MDCX earnings in the past year totalled -$16.51 million.
What are Medicus Pharma's earnings expectations?
The current EPS estimate for Medicus Pharma's earnings report in Invalid Date is -$0.25.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.